Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Privia Health (PRVA) Enterprise Value (2020 - 2025)

Privia Health has reported Enterprise Value over the past 6 years, most recently at -$426.0 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$426.0 million for Q4 2025, up 3.82% from a year ago — trailing twelve months through Dec 2025 was -$426.0 million (up 3.82% YoY), and the annual figure for FY2025 was -$426.0 million, up 3.82%.
  • Enterprise Value for Q4 2025 was -$426.0 million at Privia Health, down from -$387.7 million in the prior quarter.
  • Over the last five years, Enterprise Value for PRVA hit a ceiling of -$84.8 million in Q1 2021 and a floor of -$442.9 million in Q4 2024.
  • Median Enterprise Value over the past 5 years was -$316.6 million (2022), compared with a mean of -$322.1 million.
  • Peak annual rise in Enterprise Value hit 19.5% in 2022, while the deepest fall reached 245.54% in 2022.
  • Privia Health's Enterprise Value stood at -$297.3 million in 2021, then fell by 10.35% to -$328.0 million in 2022, then decreased by 4.73% to -$343.6 million in 2023, then decreased by 28.91% to -$442.9 million in 2024, then rose by 3.82% to -$426.0 million in 2025.
  • The last three reported values for Enterprise Value were -$426.0 million (Q4 2025), -$387.7 million (Q3 2025), and -$339.4 million (Q2 2025) per Business Quant data.